Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a condition where stomach contents reflux causes troublesome symptoms like heartburn and regurgitation, GERD’s diagnosis often involves endoscopy and reflux monitoring, especially for patients unresponsive to initial treatments. Advanced diagnostic tools such as pH or impedance-pH monitoring and high-resolution esophageal manometry help clinicians confirm GERD and assess for surgical suitability in more severe cases. Evolving treatments include tailored use of proton pump inhibitors (PPIs), novel medical therapies, and endoscopic procedures. Explore the full article for a comprehensive review of diagnostic and management strategies that are helping clinicians better address this pervasive condition.
Trending
- A Focus on Quality Colonoscopy Bowel Preparation (GI & Endoscopy News)
- Innovating IBD Treatment Using Behavioral Health Tactics (AJMC)
- Fecal transplants: Promising treatment or potential health risk? (Medical Xpress)
- Dr Micheal Tadros on GLP-1 Agonists in Gastroenterology (Gastroenterology Learning Network)
- Why AI Can (and Will) Be a Valuable Tool in the Clinician’s Toolbox (HealthLeaders)
- Great Neck Gastroenterologist Charged with More Than $100,000 Social Security Benefits Fraud (District Attorney)
- Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening (Business Wire)
- Medicare Physician Gastrointestinal Procedure Pay Fell; Facility Pay Rose (Medscape)